2019
DOI: 10.3899/jrheum.171411
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study

Abstract: Objective.The purpose of the ULISSE study was to evaluate the prevalence of clinical and ultrasonographic (US) entheseal involvement in patients with psoriatic arthritis (PsA), psoriasis, and fibromyalgia syndrome (FMS).Methods.In this cross-sectional multicenter study, patients with PsA and psoriasis (not taking systemic therapy) and FMS underwent a clinical evaluation of the entheses, and a B-mode and power Doppler examination of 6 pairs of entheses.Results.The study analyzed 140 patients with PsA, 51 with p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
56
2
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 69 publications
(65 citation statements)
references
References 31 publications
4
56
2
3
Order By: Relevance
“…Both ultrasound (US) and MRI are able to provide objective evidence of inflammation at entheses, certainly when there is patient–evaluator discordance, since a significant proportion of patients with PsA may have coexisting central sensitisation syndrome, which may bias clinical outcome measures. 20 In recent years, several enthesitis US scoring systems have been published; however, as each is different by incorporating different US elementary lesions, comparison across studies and the use of US as outcome measurement instrument of enthesitis in multicenter studies are problematic. 21 In 2018, the OMERACT US enthesitis Working Group produced a final reliable US score and definition of enthesitis in SpA/PsA.…”
Section: Diagnosismentioning
confidence: 99%
“…Both ultrasound (US) and MRI are able to provide objective evidence of inflammation at entheses, certainly when there is patient–evaluator discordance, since a significant proportion of patients with PsA may have coexisting central sensitisation syndrome, which may bias clinical outcome measures. 20 In recent years, several enthesitis US scoring systems have been published; however, as each is different by incorporating different US elementary lesions, comparison across studies and the use of US as outcome measurement instrument of enthesitis in multicenter studies are problematic. 21 In 2018, the OMERACT US enthesitis Working Group produced a final reliable US score and definition of enthesitis in SpA/PsA.…”
Section: Diagnosismentioning
confidence: 99%
“…The DAS28 score is inappropriate for assessing joint disease activity in PsA because joints below the knee are not counted 5 . And the authors also correctly point out that the groups were not matched for age, sex, and body mass index, all of which can influence US scores, although regression analysis allowed for these differences 4 .…”
Section: Assessment Of Enthesitis In Psoriatic Arthritismentioning
confidence: 99%
“…In this issue of The Journal, Macchioni and colleagues provide some further insights 4 . In a well-designed multicenter study they examined entheses of patients with PsA, psoriasis, and FM, both by clinical examination and with US.…”
Section: Assessment Of Enthesitis In Psoriatic Arthritismentioning
confidence: 99%
See 1 more Smart Citation
“…Lastly, a prodromal symptomatic transition phase may exist characterized by nonspecific musculoskeletal pain, recently defined as psoriatic arthralgia, and fatigue [ 8 , 20 ]. This prodromal phase can be difficult to identify due to non-specific symptoms and possible PsA disease mimics, such as incipient or concomitant osteoarthritis, fibromyalgia, or chronic pain related to psoriatic comorbidities [ 21 , 22 , 23 ]. There are preliminary evidences that sonographic determined enthesitis might be associated with subsequent clinical disease evolution [ 20 , 24 , 25 ], but these results are preliminary and require further validation.…”
Section: From Pso To Psa In the Dermatology-rheumatology Combined mentioning
confidence: 99%